MC10 grabs $19.8M more to advance stretchable sensors for med tech

The Bay State's MC10--a maker of stretchable sensors useful for medical devices and other applications--reeled in $19.8 million in new funding, according to a regulatory filing.

The Boston Business Journal reported on Cambridge-based MC10's latest equity financing, which comes on top of an $18 million funding round in April. MC10's filing doesn't disclose the investors behind the round. But as the BBJ noted, Braemar Energy Ventures and North Bridge Venture Partners are among the company's previous investors. Medtronic ($MDT) is also an investor and has partnered with MC10 to use its BioStamp stretchable sensor technology in a balloon catheter, a bid to develop a device that can open up vessels and simultaneously collect data on heart function and potential vascular problems.

In July, MC10 heralded a deal with Reebok ($RBK) that produced a device worn on the head to detect head trauma severity in contact sports such as football. While not designed to function as a diagnostic, the product is designed to help reduce the risk of serious injury by determining an athlete's condition on the field.

- here's the SEC filing
- check out the BBJ's take

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.